FDA Drug · D-0744-2026

Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1

Class I · Ongoing

Presence of Particulate Matter; identified as stainless steel

Affected lots / codes — check yours against thisLot # V24010V1, Exp 3/31/2027

Recalling firm: Sunny Pharmtech Inc., Taoyuan City,
Classification: Class I (most serious — risk of serious harm)
Status: Ongoing
Quantity: 1,464 vials
Distribution: USA Nationwide
Recall initiated: July 17, 2026
Classified: August 7, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0744-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →